Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Why Pfizer Stock Slipped Today
09:26pm, Thursday, 11'th Aug 2022 The Motley Fool
Investors appear to have a case of heartburn over lawsuits related to Zantac.
U.S. stocks end mixed as rally tied to cooler inflation data takes breather
08:45pm, Thursday, 11'th Aug 2022 MarketWatch
Stocks finish mostly lower Thursday, despite hitting a three-month high in morning action after another batch of July data suggested U.S. inflation may be easing.
Why GSK Is So Deep in the Red Today
06:51pm, Thursday, 11'th Aug 2022 The Motley Fool
A wave of litigation is coming into view.
Biotech Stock Roundup: AMGN's Q2 Earnings, CCXI Acquisition & More Updates
03:25pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Earnings updates from Amgen (AMGN) and its ChemoCentryx (CCXI) acquisition are a few key highlights from the biotech sector during the past week.
Why GSK Is So Deep in the Red Today
02:51pm, Thursday, 11'th Aug 2022
A wave of litigation is coming into view.
GSK, PFE, SNY Stocks Fall on Zantac Litigation
11:34am, Thursday, 11'th Aug 2022
Source: Willy Barton / Shutterstock.com Investors in GSK (NYSE: GSK ) stock, Pfizer (NYSE: PFE ) and Sanofi (NASDAQ: SNY ) are all feeling the heat today. Reportedly, they're concerned about legal pos
GSK and Haleon given headache by cancer-linked heartburn drug
11:08am, Thursday, 11'th Aug 2022
GSK PLC (LSE:GSK, NYSE:GSK) and Haleon PLC (LSE:HLN, NYSE:HLN) were the biggest FTSE 100 fallers on Thursday amid investor concerns surrounding US lawsuits over heartburn drug, which was withdrawn fr
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
10:38am, Thursday, 11'th Aug 2022
Pharmaceutical stocks GSK, Sanofi and Haleon extended deep losses Thursday amid looming litigation around recalled heartburn drug Zantac. The post Pharma Stocks GSK, Sanofi And Haleon Lose Billions As
Drug stocks under pressure over Zantac litigation concerns
10:35am, Thursday, 11'th Aug 2022
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss alleged concerns that Sanofi and GSK's antacid drug Zantac causes cancer.
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
10:03am, Thursday, 11'th Aug 2022 Benzinga
Sonos, Inc. (NASDAQ: SONO) shares fell 20.4% to $18.11 in pre-market trading after the company reported weaker-than-expected sales results for its third quarter and issued downbeat FY22 sales guidance
GSK, Sanofi and Haleon slump on worries over Zantac litigation
07:18am, Thursday, 11'th Aug 2022
European-listed shares of drugmakers Haleon HLN, -11.81% , GSK GSK, -8.48% and Sanofi SAN, -8.81% plunged on Thursday on worries over the Zantac heartburn medication litigation. The first trial is set
Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline
03:53pm, Friday, 05'th Aug 2022 Zacks Investment Research
Theravance (TBPH) reports narrower-than-expected loss in the second quarter of 2022. Revenues improve year over year due to Viatris collaboration.
Gilead (GILD) Q2 Earnings & Sales Top, Revenue Outlook Upped
01:53pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Gilead (GILD) reports better-than-expected second quarter results on strong HIV business. The company also raises its annual revenue guidance.
Is Nuveen ESG International Developed Markets Equity ETF (NUDM) a Strong ETF Right Now?
10:20am, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Smart Beta ETF report for NUDM
The Zacks Analyst Blog Highlights GSK, Merck, Pfizer, Sanofi and AstraZeneca
12:10pm, Monday, 01'st Aug 2022 Zacks Investment Research
GSK, Merck, Pfizer, Sanofi and AstraZeneca are part of Zacks top Analyst Blog.
